Abstract: The present invention relates to methods for producing dairy food products modified with respect to their firmness and/or gelation time comprising cross-linked protein compounds and to methods for modifying said properties of said dairy food products, as well as to said modified dairy food products obtainable or obtained by such methods. Modification is achieved by in situ generation of H2O2 via carbohydrate oxidase, preferably cellobiose oxidase (EC 1.1.99.18), and cross-linking protein-tyrosine residues in a reaction using H202 via peroxidase (EC 1.11.1.7). Adding small phenolic compounds such as preferably p-coumaric acid or vanillin allows better control of the cross-linking reaction.
Type:
Application
Filed:
May 15, 2020
Publication date:
July 7, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Surender Kumar DHAYAL, Martin LUND, Henrik BISGAARD-FRANTZEN, Johannes Maarten VAN DEN BRINK
Abstract: The present invention relates to a novel Lactobacillus strain that is not attacked by common phages and a novel Lactobacillus strain with improved cell count stability, its use in the manufacture of fermented milk-based products, and novel milk based products containing the strain.
Abstract: The present invention relates to a composition suitable for preparing a dairy product comprising at least one starter culture and a Lactobacillus rhamnosus strain capable of imparting onto the dairy product an enhanced creamy flavor without affecting the rheology negatively, the fermentation time or the post-acidification of the dairy product. The present invention further relates to processes for preparing a dairy product, such as a low-fat yogurt or cheese, which has a high content of diacetyl. A Lactobacillus rhamnosus strain useful for preparing such dairy product is also part of the present invention.
Abstract: The present invention provides a new wine yeast product in a frozen form. The product is produced in a fermenter, concentrated, cryoprotectants are added. This mixture is then frozen at ?50° C. What makes this product unique is that besides the fact that it is frozen, it can be directly added to grape juice as no rehydration is required because the yeast was not dehydrated in the production process.
Type:
Grant
Filed:
April 26, 2011
Date of Patent:
April 26, 2022
Assignee:
CHR. HANSEN A/S
Inventors:
Jan Hendrik Sweigers, Annicka Bunte, Sylvester Holt, Mansour Badaki
Abstract: The present invention relates to a silage inoculant consisting essentially of a) at least one obligatory heterofermentative lactic acid bacterial species or strain and b) at least one homofermentative bacterial species or strain which (i) does not reduce growth of a), and (ii) reduces pH fast without producing an excess amount of lactic acid. Further, the invention relates to a method for producing a fermented feed product, said method comprising inoculating a plant material with the silage inoculant according to the invention. It has surprisingly been found that the silage inoculant is effective even if the silage has only been incubated for a period of up to 2 or up to 4 days.
Type:
Application
Filed:
October 27, 2021
Publication date:
April 21, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Ida HINDRICHSEN, Nina MILORA, Christer OHLSSON
Abstract: The present invention provides a Bacillus subtilis strain selected from the group consisting of a) the strain deposited as DSM32324, b) the strain deposited as DSM32325, and c) a mutant strain of (a) or (b) which has sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline, and chloramphenicol; and has inhibitory activity against E. coli and Clostridium perfringens. The invention further relates to Bacillus compositions comprising at least one Bacillus subtilis strain of the invention, preferably the Bacillus subtilis strain DSM32324 and/or the Bacillus subtilis strain DSM32325, as Direct Fed Microbial (DFM), premix, animal feed additive or animal feed.
Abstract: The present invention relates to a bacterial cell with texturizing property, starter cultures comprising the cell, and dairy products manufactured using the bacterial cell.
Type:
Grant
Filed:
August 24, 2017
Date of Patent:
March 15, 2022
Assignee:
CHR. HANSEN A/S
Inventors:
Patrick Derkx, Thomas Janzen, Kim Ib Soerensen
Abstract: The dairy industry today faces a problem of providing an alternative to adding sweeteners to fermented milk products in order to achieve the desired sweet taste without the added calories. Furthermore, it would be highly advantageous to establish a method for reducing lactose in fermented milk products to a level which is acceptable for lactose-intolerant consumers. The above problems have been solved by providing mutant Streptococcus thermophilus strains and mutant Lactobacillus delbrueckii subsp. bulgaricus strains that excrete glucose to the milk when the milk is inoculated and fermented with such Streptococcus thermophilus strains and Lactobacillus delbrueckii subsp, bulgaricus strains.
Type:
Application
Filed:
July 30, 2021
Publication date:
March 3, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Eric JOHANSEN, Kim Ib SOERENSEN, Mirjana CURIC-BAWDEN, Mette Pia JUNGE
Abstract: A method for making a new food, feed or pharmaceutical product comprising addition of a composition comprising cross-linked, via intermolecular covalent isopeptide bonds, casein glycomacropeptide (CGMP) oligomers (CGMP oligomers) to the product.
Type:
Grant
Filed:
January 8, 2018
Date of Patent:
February 15, 2022
Assignee:
CHR. HANSEN A/S
Inventors:
Surender Kumar Dhayal, Martin Lund, Johannes Maarten Van Den Brink
Abstract: The present invention relates to a method for making Cheddar type and Continental type cheese with an adjunct culture comprising a Lactobacillus helveticus strain.
Abstract: The present invention relates to a process for obtaining a biomass composition of a bacterium strain with bactericidal activity which inhibits or kills various pathogenic bacteria.
Type:
Application
Filed:
November 29, 2019
Publication date:
February 3, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Birgitte YDE, Hans BISGAARD-FRANTZEN, Jacob KAYA
Abstract: A liquid or dried granulated milk clotting aspartic protease enzyme composition and process for isolating a milk clotting aspartic protease enzyme of interest.
Type:
Grant
Filed:
September 17, 2020
Date of Patent:
February 1, 2022
Assignee:
CHR. HANSEN A/S
Inventors:
Martin Lund, Jonas Jacobsen, Johannes Maarten Van Den Brink
Abstract: The present invention is in the field of dairy technology. It relates to methods of inhibiting the growth of unwanted microorganisms, such as Gram-negative bacteria, yeasts or molds in dairy products by using phospholipase to treat the milk base. The invention also provides dairy products produced therefrom.
Type:
Application
Filed:
November 8, 2019
Publication date:
January 13, 2022
Applicant:
Chr. Hansen A/S
Inventors:
Sebastien ROUSTEL, Michael Mitsuo SAITO
Abstract: The present invention relates to a composition suitable for preparing a dairy product comprising at least one starter culture and a Lactobacillus rhamnosus strain capable of imparting onto the dairy product an enhanced creamy flavor without affecting the rheology negatively, the fermentation time or the post-acidification of the dairy product. The present invention further relates to processes for preparing a dairy product, such as a low-fat yogurt or cheese, which has a high content of diacetyl. A Lactobacillus rhamnosus strain useful for preparing such dairy product is also part of the present invention.
Abstract: The present invention relates to new improved peptide or dimeric peptides exhibiting betagalactosidase enzyme activity as well as improved methods for reducing the lactose content in compositions, such as dairy products.
Type:
Application
Filed:
April 11, 2018
Publication date:
November 18, 2021
Applicant:
Chr. Hansen A/S
Inventors:
Hans RAJ, Pernille SMITH, Thomas ECKHARDT, Vojislav VOJINOVIC, Charlotte Elisabeth Grüner SCHÖLLER, Johannes Maarten VAN DEN BRINK
Abstract: The present invention relates to new improved peptide or dimeric peptides exhibiting betagalactosidase enzyme activity wherein the peptide has a pH optimum at acidic conditions.
Type:
Application
Filed:
October 17, 2019
Publication date:
November 11, 2021
Applicant:
Chr. Hansen A/S
Inventors:
Hans RAJ, Johannes Maarten VAN DEN BRINK, Christian GILLELADEN
Abstract: The present invention relates to novel S. thermophillus strains that are not attacked by common phagesand novel Streptococcus strains with improved stability against phage attacks, methods to obtain Streptococcus strains with improved phage resistance, their use in the manufacture of fermented milk-based products, and novel milk based products containing the strain.
Type:
Application
Filed:
July 15, 2019
Publication date:
November 4, 2021
Applicant:
Chr. Hansen A/S
Inventors:
Paula SZYMCZAK, Thomas JANZEN, Rute NEVES